Literature DB >> 22366508

Successful steroid therapy for heart failure due to myocarditis associated with primary biliary cirrhosis.

Kensuke Matsumoto1, Hidekazu Tanaka, Shota Yamana, Akihiro Kaneko, Takayuki Tsuji, Keiko Ryo, Kenji Sekiguchi, Fumi Kawakami, Hiroya Kawai, Ken-ichi Hirata.   

Abstract

This report concerns a 65-year-old woman with primary biliary cirrhosis (PBC) featuring high titers of M2 antimitochondrial antibody who developed intractable heart failure (HF). Although the etiology is unclear, involvement of skeletal muscles has been reported with PBC as a result of mitochondrial damage from the autoimmune process. In this case, histopathological examination and (18)F-fluorodeoxy glucose-positron emission tomography imaging revealed myocarditis concomitant with myositis. The patient showed favourable response to high-dose corticosteroid administration. To the best of our knowledge, this is the first case of HF with myocarditis and polymyositis associated with asymptomatic PBC who was successfully treated with prednisolone.
Copyright © 2012 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22366508     DOI: 10.1016/j.cjca.2011.12.010

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  8 in total

1.  Connective tissue diseases in primary biliary cirrhosis: a population-based cohort study.

Authors:  Li Wang; Feng-Chun Zhang; Hua Chen; Xuan Zhang; Dong Xu; Yong-Zhe Li; Qian Wang; Li-Xia Gao; Yun-Jiao Yang; Fang Kong; Ke Wang
Journal:  World J Gastroenterol       Date:  2013-08-21       Impact factor: 5.742

2.  Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement.

Authors:  Jemima Albayda; Aamna Khan; Livia Casciola-Rosen; Andrea M Corse; Julie J Paik; Lisa Christopher-Stine
Journal:  Semin Arthritis Rheum       Date:  2017-06-13       Impact factor: 5.532

3.  Anti-mitochondrial M2 Antibodies Enhance the Risk of Supraventricular Arrhythmias in Patients with Elevated Hepatobiliary Enzyme Levels.

Authors:  Hiroki Konishi; Koji Fukuzawa; Shumpei Mori; Seimi Satomi-Kobayashi; Kunihiko Kiuchi; Atsushi Suzuki; Yoshihiko Yano; Akihiro Yoshida; Ken-Ichi Hirata
Journal:  Intern Med       Date:  2017-07-15       Impact factor: 1.271

4.  Anti-mitochondrial Antibodies in Patients with Dilated Cardiomyopathy.

Authors:  Tetsuro Yokokawa; Akiomi Yoshihisa; Tomofumi Misaka; Takamasa Sato; Takashi Kaneshiro; Masayoshi Oikawa; Atsushi Kobayashi; Takayoshi Yamaki; Hiroyuki Kunii; Yasuchika Takeishi
Journal:  Intern Med       Date:  2021-01-15       Impact factor: 1.271

5.  QTc interval prolongation in the patients with primary biliary cholangitis.

Authors:  Zihao Wang; Rongkai Qian; Yanhua Wang; Lingfei Mo; Bomiao Ju; Nan Hu; Pei Wang; Lan He; Jing Wang
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-12-02       Impact factor: 1.468

6.  Cardiac involvement in patients with primary biliary cholangitis: A 14-year longitudinal survey-based study.

Authors:  Sainan Bian; Hua Chen; Li Wang; Yunyun Fei; Yunjiao Yang; Linyi Peng; Yongzhe Li; Fengchun Zhang
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

7.  Antimitochondrial Antibody-associated Myopathy with Slowly Progressive Cardiac Dysfunction.

Authors:  Fumihiko Takahashi; Jun Sawada; Akiho Minoshima; Naka Sakamoto; Toshiyuki Ono; Kazumi Akasaka; Hidehiro Takei; Ichizo Nishino; Naoyuki Hasebe
Journal:  Intern Med       Date:  2020-10-28       Impact factor: 1.271

8.  Life-threatening ventricular arrhythmia and left ventricular dysfunction associated with anti-mitochondrial antibody-positive myositis: a case report.

Authors:  Yuki Hasegawa; Daisuke Izumi; Takeshi Kashimura; Tohru Minamino
Journal:  Eur Heart J Case Rep       Date:  2021-12-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.